A carregar...
Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence
The mechanistic target of rapamycin (mTOR) drives several physiologic and pathologic cellular processes and is frequently deregulated in different types of tumors, including glioblastoma (GBM). Despite recent advancements in understanding the molecular mechanisms involved in GBM biology, the surviva...
Na minha lista:
| Publicado no: | Dis Markers |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6312595/ https://ncbi.nlm.nih.gov/pubmed/30662577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9230479 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|